Summary
Patients trying to get the weight-loss drug Mounjaro are facing difficulties due to increased demand and an impending price rise. The manufacturer, Eli Lilly, is raising the price by up to 170%, causing short-term supply issues. Pharmacies are advising patients to avoid stockpiling the drug.
Key Facts
- Patients are struggling to get Mounjaro, a weight-loss drug, as demand rises before a price increase.
- Eli Lilly, the drug's manufacturer, announced that prices will go up by up to 170% starting 1 September.
- UK pharmacies are prioritizing patients already using the drug and expect normal supply soon.
- A UK patient, Lynne Massey-Davis, shared her struggle to obtain the drug, affecting her health routine.
- The National Pharmacy Association reported increased demand and supply pressures due to the price hike.
- Pharmacies urge patients not to bulk buy or use unlicensed sellers due to safety risks.
- There's advice for patients to consider alternative weight-loss drugs only with medical advice.
